1
|
Kara SS, Polat M, Erdeniz EH, Donmez AS. Pediatric Oropharyngeal Tularemia Cases: Challenges in Management. Vector Borne Zoonotic Dis 2024. [PMID: 38651622 DOI: 10.1089/vbz.2023.0076] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 04/25/2024] Open
Abstract
Background: Tularemia is one of the most prevalent zoonoses across the world. Patients in Turkiye mostly contract the oropharyngeal form, acquired through drinking, or contact with microorganism-contaminated water. Methods: Patients with oropharyngeal tularemia aged under 18 years and diagnosed between January 01, 2017, and December 31, 2020, were evaluated retrospectively. Tularemia was diagnosed in patients with compatible histories, symptoms, clinical presentations, and laboratory test results. Results: The mean age of 38 children was 12.1 ± 3.4 years, and the female/male ratio was 0.58 (14/24). The mean duration of symptoms on admission was 33.8 ± 26.2 days. All children had enlarged lymph nodes. Malaise, fever, and loss of appetite were other frequent symptoms. Patients were treated with antibiotics for a mean of 26.2 ± 18.8 days. Gentamycin was the most frequently used antibiotic (either alone or in combination) (n = 29, 76.3%). Twenty-six (68.4%) patients underwent surgical procedures in addition to antibiotherapy. Five (13.2%) required secondary total excision. Patients with higher leukocyte counts at admission received a combination of antibiotherapy plus surgery, rather than antibiotics alone. No relapses, reretreatment requirement, or mortality were observed after 12 months of follow-up. Conclusions: Oropharyngeal tularemia in children can require longer courses of antibiotic treatment with more than one drug and more frequent surgery than previously suggested in the literature, especially if the patients are admitted late to the hospital, symptom duration is prolonged, and appropriate treatment is initiated late. Higher leukocyte counts on admission may be prognostic for longer antibiotic treatment course and suppurative complications that require surgery. Raising awareness among patients and physicians is essential.
Collapse
Affiliation(s)
- Soner Sertan Kara
- Department of Pediatric Infectious Diseases, Aydin Adnan Menderes University, Aydin, Turkiye
- Department of Pediatric Infectious Diseases, Erzurum Regional Training and Research Hospital, Erzurum, Turkiye
| | - Meltem Polat
- Department of Pediatric Infectious Diseases, Erzurum Regional Training and Research Hospital, Erzurum, Turkiye
- Department of Pediatric Infectious Diseases, Gazi University, Ankara, Turkiye
| | - Emine Hafize Erdeniz
- Department of Pediatric Infectious Diseases, Erzurum Regional Training and Research Hospital, Erzurum, Turkiye
- Department of Pediatric Infectious Diseases, Samsun Ondokuz Mayis University, Samsun, Turkiye
| | - Ayşe Sena Donmez
- Department of Pediatrics, Erzurum Regional Training and Research Hospital, Erzurum, Turkiye
| |
Collapse
|
2
|
Yilmaz D, Ekemen Keles Y, Emiroglu M, Duramaz BB, Ugur C, Aldemir Kocabas B, Celik T, Ozdemir H, Bayturan S, Turel O, Erdeniz EH, Cakici O, Cakmak Taskin E, Erbas İC, Genceli M, Sari EE, Caymaz C, Kizil MC, Sutcu M, Demirbuga A, Alkan G, Bagcı Z, Timurtas Dayar G, Ozkan EA, Tekin Yilmaz A, Akca M, Yesil E, Kara SS, Akturk H, Yasar B, Umit Z, Uygun H, Erdem N, Buyukcam A, Karadag Oncel E, Tuter Oz SK, Cetin HS, Anil AB, Yilmaz R, Zengin N, Uzuner S, Albayrak H, Borakay O, Topal S, Arslan G, Yazar A, Ozer A, Kendirli T, Kara EM, Demirkol D, Battal F, Kosker M, Metin Akcan O, Kihtir HS, Gul D, Zararci K, Alakaya M, Kula N, Celik E, Petmezci E, Evren G, Kara Aksay A, Konca C, Sert A, Arslan D, Bornaun H, Tekeli O, Bal A, Sahin IO, Demir S, Sap F, Akyol MB, Tanidir IC, Donmez YN, Ucar T, Coban S, Arga G, Hancerli Torun S, Karpuz D, Celik SF, Varan C, Elmali F, Oncel S, Belet N, Hatipoglu N, Dalgic Karabulut N, Turgut M, Somer A, Kuyucu N, Dinleyici EC, Ciftci E, Kara A. Evaluation of 601 children with multisystem inflammatory syndrome (Turk MISC study). Eur J Pediatr 2023; 182:5531-5542. [PMID: 37782350 DOI: 10.1007/s00431-023-05207-6] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Received: 04/05/2023] [Revised: 09/09/2023] [Accepted: 09/15/2023] [Indexed: 10/03/2023]
Abstract
PURPOSE Due to its link with the 2019 coronavirus, the multisystem inflammatory syndrome in children (MISC) has garnered considerable international interest. The aim of this study, in which MISC patients were evaluated multicenter, and the data of the third period of the Turk-MISC study group, to compare the clinical and laboratory characteristics and outcomes of MISC patients who did and did not require admission to an intensive care unit (ICU). METHODS This retrospective multicenter observational study was carried out between June 11, 2021, and January 01, 2022. The demographics, complaints, laboratory results, system involvements, and outcomes of the patients were documented. RESULTS A total of 601 patients were enrolled; 157 patients (26.1%) required hospitalization in the intensive care unit (ICU). Median age was 8 years (interquartile range (IQR) 4.5-11.3 years. The proportion of Kawasaki disease-like features in the ICU group was significantly higher than in the non-ICU group (56.1% vs. 43.2% p = 0.006). The ICU group had considerably lower counts of both lymphocytes and platelets (lymphocyte count 900 vs. 1280 cells × μL, platelet count 153 vs. 212 cells × 103/ μL, all for p< 0.001). C-reactive protein, procalcitonin, and ferritin levels were significantly higher in the ICU group (CRP 164 vs. 129 mg/L, procalcitonin 9.2 vs. 2.2 μg/L, ferritin 644 vs. 334 μg/L, all for p< 0.001). Being between ages 5-12 and older than 12 increased the likelihood of hospitalization in the ICU by four [95% confidence intervals (CI)1.971-8.627] and six times (95% CI 2.575-14.654), respectively, compared to being between the ages 0-5. A one-unit increase in log D-dimer (µg/L) and log troponin (ng/L) was also demonstrated to increase the need for intensive care by 1.8 (95% CI 1.079-3.233) and 1.4 times (95% CI 1.133-1.789), respectively. Conclusion: By comparing this study to our other studies, we found that the median age of MISC patients has been rising. Patients requiring an ICU stay had considerably higher levels of procalcitonin, CRP, and ferritin but significantly lower levels of lymphocyte and thrombocyte. In particular, high levels of procalcitonin in the serum might serve as a valuable laboratory marker for anticipating the need for intensive care. WHAT IS KNOWN • Lymphopenia and thrombocytopenia were an independent predictor factors in patients with MISC who needed to stay in intensive care unit. • The possibility of the need to stay in the intensive care unit in patients with MISC who had Kawasaki disease-like findings was controversial compared with those who did not. WHAT IS NEW • A one-unit increase log D dimer and log troponin was demonstrated to require for intensive care unit by 1.8 and 1.4 times, respectively. • Serum procalcitonin levels had the best performance to predict stay in the intensive care unit stay.
Collapse
Affiliation(s)
| | - Yildiz Ekemen Keles
- Health Sciences University Tepecik Training and Research Hospital, Clinic of Pediatric Infectious Diseases, Gaziler Street Number: 468, 35020, Yenisehir Konak/Izmir, Turkey.
| | | | | | - Cuneyt Ugur
- University of Health Sciences Konya Health Application and Research Center, Konya, Turkey
| | | | - Talyan Celik
- Canakkale On Sekiz Mart University Hospital, Canakkale, Turkey
| | - Halil Ozdemir
- Department of Pediatric Infectious Diseases, Faculty of Medicine, Ankara University, Ankara, Turkey
| | | | - Ozden Turel
- Bezmialem Vakif University Hospital, Istanbul, Turkey
| | | | | | | | | | | | - Emine Ergul Sari
- Health Science University İstanbul Bakırkoy Dr. Sadi Konuk Training and Research Hospital TR, Istanbul, Turkey
| | - Canan Caymaz
- Başakşehir Cam ve Sakura City Hospital, Istanbul, Turkey
| | | | - Murat Sutcu
- İstinye University Hospital, Istanbul, Turkey
| | | | | | - Zafer Bagcı
- University of Health Sciences Konya Health Application and Research Center, Konya, Turkey
| | | | | | | | | | | | | | | | - Belma Yasar
- Health Sciences University Sisli Hamidiye Etfal Training and Research Hospital, Istanbul, Turkey
| | | | - Hatice Uygun
- Adıyaman Research and Training Hospital, Adiyaman, Turkey
| | | | - Ayse Buyukcam
- Ankara Gulhane Research and Training Hospital, Ankara, Turkey
| | - Eda Karadag Oncel
- Health Sciences University Tepecik Training and Research Hospital, Clinic of Pediatric Infectious Diseases, Gaziler Street Number: 468, 35020, Yenisehir Konak/Izmir, Turkey
| | | | | | - Ayse Berna Anil
- Health Sciences University Tepecik Training and Research Hospital, Clinic of Pediatric Infectious Diseases, Gaziler Street Number: 468, 35020, Yenisehir Konak/Izmir, Turkey
- Pediatric Intensive Care, Health Sciences University Tepecik Training and Research Hospital, Izmir, Izmir, Turkey
| | | | | | - Selcuk Uzuner
- Bezmialem Vakif University Hospital, Istanbul, Turkey
| | | | | | - Sevgi Topal
- Erzurum Regional Training and Research Hospital, Erzurum, Turkey
| | - Gazi Arslan
- Dokuz Eylül University Hospital, Izmir, Turkey
| | - Abdullah Yazar
- Necmettin Erbakan University, Meram Hospital, Konya, Turkey
| | - Arife Ozer
- Health Sciences University Van Training and Research Hospital, Van, Turkey
| | - Tanil Kendirli
- Department of Pediatric Infectious Diseases, Faculty of Medicine, Ankara University, Ankara, Turkey
- Pediatric Intensive Care, Ankara University Hospital, Ankara, Turkey
| | | | | | - Fatih Battal
- Canakkale On Sekiz Mart University Hospital, Canakkale, Turkey
| | | | | | | | - Doruk Gul
- İstinye University Hospital, Istanbul, Turkey
| | | | | | - Nilgun Kula
- Antalya Training and Research Hospital, Antalya, Turkey
| | - Elif Celik
- Aydin Adnan Menderes University Hospital, Aydin, Turkey
| | - Ercument Petmezci
- Health Sciences University Sisli Hamidiye Etfal Training and Research Hospital, Istanbul, Turkey
| | | | - Ahu Kara Aksay
- Health Sciences University Tepecik Training and Research Hospital, Clinic of Pediatric Infectious Diseases, Gaziler Street Number: 468, 35020, Yenisehir Konak/Izmir, Turkey
| | - Capan Konca
- Adiyaman University Hospital, Adiyaman, Turkey
| | - Ahmet Sert
- Selcuk University Hospital, Konya, Turkey
| | - Derya Arslan
- University of Health Sciences Konya Health Application and Research Center, Konya, Turkey
| | - Helen Bornaun
- Kanuni Sultan Süleyman Training and Research Hospital, Istanbul, Turkey
| | - Onur Tekeli
- Antalya Training and Research Hospital, Antalya, Turkey
| | - Alkan Bal
- Celal Bayar University Hospital, Manisa, Turkey
| | | | - Selcan Demir
- Erzurum Regional Training and Research Hospital, Erzurum, Turkey
| | - Fatih Sap
- Necmettin Erbakan University, Meram Hospital, Konya, Turkey
| | - Mehmet Bedir Akyol
- Health Science University İstanbul Bakırkoy Dr. Sadi Konuk Training and Research Hospital TR, Istanbul, Turkey
| | | | | | - Tayfun Ucar
- Department of Pediatric Infectious Diseases, Faculty of Medicine, Ankara University, Ankara, Turkey
- Pediatric Cardiology, Ankara University Hospital, Ankara, Turkey
| | - Senay Coban
- Erzurum Regional Training and Research Hospital, Erzurum, Turkey
| | - Gul Arga
- Department of Pediatric Infectious Diseases, Faculty of Medicine, Ankara University, Ankara, Turkey
| | | | | | | | - Celal Varan
- Adiyaman University Hospital, Adiyaman, Turkey
| | | | - Selim Oncel
- Kocaeli University Hospital, Kocaeli, Turkey
| | | | - Nevin Hatipoglu
- Health Science University İstanbul Bakırkoy Dr. Sadi Konuk Training and Research Hospital TR, Istanbul, Turkey
| | - Nazan Dalgic Karabulut
- Health Sciences University Sisli Hamidiye Etfal Training and Research Hospital, Istanbul, Turkey
| | | | - Ayper Somer
- Istanbul University Hospital, Istanbul, Turkey
| | | | | | - Ergin Ciftci
- Department of Pediatric Infectious Diseases, Faculty of Medicine, Ankara University, Ankara, Turkey
| | - Ates Kara
- Hacettepe University Hospital, Ankara, Turkey
| |
Collapse
|
3
|
Erbaş İC, Keleş YE, Erdeniz EH, Yılmaz AT, Yeşil E, Çakıcı Ö, Akça M, Ulu NK, Dinç F, Çiftdoğan DY, Öncel S, Kuyucu N, Tapısız A, Belet N. Evaluation of possible COVID-19 reinfection in children: A multicenter clinical study. Arch Pediatr 2023; 30:187-191. [PMID: 36804354 PMCID: PMC9902289 DOI: 10.1016/j.arcped.2023.01.008] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 04/25/2022] [Revised: 08/17/2022] [Accepted: 01/07/2023] [Indexed: 02/10/2023]
Abstract
BACKGROUND Although it was originally unknown whether there would be cases of reinfection of coronavirus disease 2019 (COVID-19) as seen with other coronaviruses, cases of reinfection were reported from various regions recently. However, there is little information about reinfection in children. METHODS In this study, we aimed to investigate the incidence and clinical findings of reinfection in pediatric patients who had recovered from COVID-19. We retrospectively evaluated all patients under 18 years of age with COVID-19 infection from a total of eight healthcare facilities in Turkey, between March 2020 and July 2021. Possible reinfection was defined as a record of confirmed COVID-19 infection based on positive reverse transcription-polymerase chain reaction (RT-PCR) test results at least 3 months apart. RESULTS A possible reinfection was detected in 11 out of 8840 children, which yielded an incidence of 0.12%. The median duration between two episodes of COVID-19 was 196 (92-483) days. When initial and second episodes were compared, the rates of symptomatic and asymptomatic disease were similar for both, as was the severity of the disease (p = 1.000). Also, there was no significant difference in duration of symptoms (p = 0.498) or in hospitalization rates (p = 1.000). Only one patient died 15 days after PCR positivity, which resulted in a 9.1% mortality rate for cases of reinfection in pediatric patients. CONCLUSION We observed that children with COVID-19 were less likely to be exposed to reinfection when compared with adults. Although the clinical spectrum of reinfection was mostly similar to the first episode, we reported death of a healthy child during the reinfection.
Collapse
Affiliation(s)
- İrem Ceren Erbaş
- Division of Pediatric Infectious Disease, Faculty of Medicine, Dokuz Eylül University, İzmir, Turkey.
| | - Yıldız Ekemen Keleş
- Division of Pediatric Infectious Disease, Tepecik Training and Research Hospital, İzmir, Turkey
| | - Emine Hafize Erdeniz
- Division of Pediatric Infectious Disease, Faculty of Medicine, On Dokuz Mayıs University, Samsun, Turkey
| | - Ayşe Tekin Yılmaz
- Division of Pediatric Infectious Disease, Eskişehir State Hospital, Eskişehir, Turkey
| | - Edanur Yeşil
- Division of Pediatric Infectious Disease, Mersin State Hospital, Mersin, Turkey
| | - Özlem Çakıcı
- Division of Pediatric Infectious Disease, Faculty of Medicine, Kocaeli University, Kocaeli, Turkey
| | - Mehtap Akça
- Division of Pediatric Infectious Disease, Faculty of Medicine, Mersin University, Mersin, Turkey
| | - Nursel Kara Ulu
- Division of Pediatric Infectious Disease, Faculty of Medicine, Gazi University, Ankara, Turkey
| | - Fatih Dinç
- Division of Virology, Faculty of Medicine, Dokuz Eylül University, İzmir, Turkey
| | - Dilek Yılmaz Çiftdoğan
- Division of Pediatric Infectious Disease, Tepecik Training and Research Hospital, İzmir, Turkey
| | - Selim Öncel
- Division of Pediatric Infectious Disease, Faculty of Medicine, Kocaeli University, Kocaeli, Turkey
| | - Necdet Kuyucu
- Division of Pediatric Infectious Disease, Faculty of Medicine, Mersin University, Mersin, Turkey
| | - Anıl Tapısız
- Division of Pediatric Infectious Disease, Faculty of Medicine, Gazi University, Ankara, Turkey
| | - Nurşen Belet
- Division of Pediatric Infectious Disease, Faculty of Medicine, Dokuz Eylül University, İzmir, Turkey
| |
Collapse
|
4
|
Kökçü Karadağ Şİ, Erdeniz EH, Özkan E, Yıldıran A. Case Series Evaluating Lymphocyte Subgroups at Diagnosis and After Treatment in Multisystem Inflammatory Syndrome Associated with COVID-19 in Children. J Pediatr Inf 2022. [DOI: 10.5578/ced.20229607] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 12/23/2022]
|
5
|
Kökçü Karadağ Şİ, Erdeniz EH, Özkan E, Yıldıran A. Çocuklarda COVID-19 ile İlişkili Multisistem Enflamatuvar Sendromunda Tanı Esnasında ve Tedavi Sonrasında Lenfosit Alt Gruplarının Değerlendirildiği Vaka Serisi. J Pediatr Inf 2022. [DOI: 10.5578/ced.20229623] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 12/23/2022]
|
6
|
Ogishi M, Arias AA, Yang R, Han JE, Zhang P, Rinchai D, Halpern J, Mulwa J, Keating N, Chrabieh M, Lainé C, Seeleuthner Y, Ramírez-Alejo N, Nekooie-Marnany N, Guennoun A, Muller-Fleckenstein I, Fleckenstein B, Kilic SS, Minegishi Y, Ehl S, Kaiser-Labusch P, Kendir-Demirkol Y, Rozenberg F, Errami A, Zhang SY, Zhang Q, Bohlen J, Philippot Q, Puel A, Jouanguy E, Pourmoghaddas Z, Bakhtiar S, Willasch AM, Horneff G, Llanora G, Shek LP, Chai LY, Tay SH, Rahimi HH, Mahdaviani SA, Nepesov S, Bousfiha AA, Erdeniz EH, Karbuz A, Marr N, Navarrete C, Adeli M, Hammarstrom L, Abolhassani H, Parvaneh N, Al Muhsen S, Alosaimi MF, Alsohime F, Nourizadeh M, Moin M, Arnaout R, Alshareef S, El-Baghdadi J, Genel F, Sherkat R, Kiykim A, Yücel E, Keles S, Bustamante J, Abel L, Casanova JL, Boisson-Dupuis S. Impaired IL-23-dependent induction of IFN-γ underlies mycobacterial disease in patients with inherited TYK2 deficiency. J Exp Med 2022; 219:e20220094. [PMID: 36094518 PMCID: PMC9472563 DOI: 10.1084/jem.20220094] [Citation(s) in RCA: 18] [Impact Index Per Article: 9.0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Grants] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 01/15/2022] [Revised: 06/21/2022] [Accepted: 07/14/2022] [Indexed: 12/21/2022] Open
Abstract
Human cells homozygous for rare loss-of-expression (LOE) TYK2 alleles have impaired, but not abolished, cellular responses to IFN-α/β (underlying viral diseases in the patients) and to IL-12 and IL-23 (underlying mycobacterial diseases). Cells homozygous for the common P1104A TYK2 allele have selectively impaired responses to IL-23 (underlying isolated mycobacterial disease). We report three new forms of TYK2 deficiency in six patients from five families homozygous for rare TYK2 alleles (R864C, G996R, G634E, or G1010D) or compound heterozygous for P1104A and a rare allele (A928V). All these missense alleles encode detectable proteins. The R864C and G1010D alleles are hypomorphic and loss-of-function (LOF), respectively, across signaling pathways. By contrast, hypomorphic G996R, G634E, and A928V mutations selectively impair responses to IL-23, like P1104A. Impairment of the IL-23-dependent induction of IFN-γ is the only mechanism of mycobacterial disease common to patients with complete TYK2 deficiency with or without TYK2 expression, partial TYK2 deficiency across signaling pathways, or rare or common partial TYK2 deficiency specific for IL-23 signaling.
Collapse
Affiliation(s)
- Masato Ogishi
- St Giles Laboratory of Human Genetics of Infectious Diseases, Rockefeller Branch, The Rockefeller University, New York, NY
| | - Andrés Augusto Arias
- St Giles Laboratory of Human Genetics of Infectious Diseases, Rockefeller Branch, The Rockefeller University, New York, NY
- Primary Immunodeficiencies Group, University of Antioquia, Medellin, Colombia
- School of Microbiology, University of Antioquia, Medellin, Colombia
| | - Rui Yang
- St Giles Laboratory of Human Genetics of Infectious Diseases, Rockefeller Branch, The Rockefeller University, New York, NY
| | - Ji Eun Han
- St Giles Laboratory of Human Genetics of Infectious Diseases, Rockefeller Branch, The Rockefeller University, New York, NY
| | - Peng Zhang
- St Giles Laboratory of Human Genetics of Infectious Diseases, Rockefeller Branch, The Rockefeller University, New York, NY
| | - Darawan Rinchai
- St Giles Laboratory of Human Genetics of Infectious Diseases, Rockefeller Branch, The Rockefeller University, New York, NY
| | - Joshua Halpern
- St Giles Laboratory of Human Genetics of Infectious Diseases, Rockefeller Branch, The Rockefeller University, New York, NY
| | - Jeanette Mulwa
- St Giles Laboratory of Human Genetics of Infectious Diseases, Rockefeller Branch, The Rockefeller University, New York, NY
| | - Narelle Keating
- St Giles Laboratory of Human Genetics of Infectious Diseases, Rockefeller Branch, The Rockefeller University, New York, NY
- Walter and Eliza Hall Institute of Medical Research, Department of Medical Biology, University of Melbourne, Melbourne, Australia
| | - Maya Chrabieh
- Laboratory of Human Genetics of Infectious Diseases, Necker Branch, INSERM U1163, Paris, France
- Paris Cité University, Imagine Institute, Paris, France
| | - Candice Lainé
- Laboratory of Human Genetics of Infectious Diseases, Necker Branch, INSERM U1163, Paris, France
- Paris Cité University, Imagine Institute, Paris, France
| | - Yoann Seeleuthner
- Laboratory of Human Genetics of Infectious Diseases, Necker Branch, INSERM U1163, Paris, France
- Paris Cité University, Imagine Institute, Paris, France
| | - Noé Ramírez-Alejo
- St Giles Laboratory of Human Genetics of Infectious Diseases, Rockefeller Branch, The Rockefeller University, New York, NY
| | - Nioosha Nekooie-Marnany
- Acquired Immunodeficiency Research Center, Isfahan University of Medical Sciences, Isfahan, Iran
| | | | | | - Bernhard Fleckenstein
- Institute of Clinical and Molecular Virology, University of Erlangen-Nuremberg, Erlangen, Germany
| | - Sara S. Kilic
- Department of Pediatric Immunology and Rheumatology, Faculty of Medicine, Uludag University, Bursa, Turkey
| | - Yoshiyuki Minegishi
- Division of Molecular Medicine, Institute of Advanced Medical Sciences, Tokushima University, Tokushima, Japan
| | - Stephan Ehl
- Institute for Immunodeficiency, Center for Chronic Immunodeficiency, Medical Center, Faculty of Medicine, University of Freiburg, Freiburg, Germany
| | | | - Yasemin Kendir-Demirkol
- Department of Pediatric Genetics, Umraniye Training and Research Hospital, University of Health Sciences, Istanbul, Turkey
| | - Flore Rozenberg
- Laboratory of Virology, Assistance Publique-Hôpitaux de Paris, Cochin Hospital, Paris, France
| | - Abderrahmane Errami
- Laboratory of Clinical Immunology, Inflammation and Allergy, Faculty of Medicine and Pharmacy, Hassan II University, Casablanca, Morocco
| | - Shen-Ying Zhang
- St Giles Laboratory of Human Genetics of Infectious Diseases, Rockefeller Branch, The Rockefeller University, New York, NY
- Laboratory of Human Genetics of Infectious Diseases, Necker Branch, INSERM U1163, Paris, France
- Paris Cité University, Imagine Institute, Paris, France
| | - Qian Zhang
- St Giles Laboratory of Human Genetics of Infectious Diseases, Rockefeller Branch, The Rockefeller University, New York, NY
- Laboratory of Human Genetics of Infectious Diseases, Necker Branch, INSERM U1163, Paris, France
- Paris Cité University, Imagine Institute, Paris, France
| | - Jonathan Bohlen
- Laboratory of Human Genetics of Infectious Diseases, Necker Branch, INSERM U1163, Paris, France
- Paris Cité University, Imagine Institute, Paris, France
| | - Quentin Philippot
- Laboratory of Human Genetics of Infectious Diseases, Necker Branch, INSERM U1163, Paris, France
- Paris Cité University, Imagine Institute, Paris, France
| | - Anne Puel
- St Giles Laboratory of Human Genetics of Infectious Diseases, Rockefeller Branch, The Rockefeller University, New York, NY
- Laboratory of Human Genetics of Infectious Diseases, Necker Branch, INSERM U1163, Paris, France
- Paris Cité University, Imagine Institute, Paris, France
| | - Emmanuelle Jouanguy
- St Giles Laboratory of Human Genetics of Infectious Diseases, Rockefeller Branch, The Rockefeller University, New York, NY
- Laboratory of Human Genetics of Infectious Diseases, Necker Branch, INSERM U1163, Paris, France
- Paris Cité University, Imagine Institute, Paris, France
| | - Zahra Pourmoghaddas
- Department of Pediatric Infectious Disease, Isfahan University of Medical Sciences, Isfahan, Iran
| | - Shahrzad Bakhtiar
- Division for Stem Cell Transplantation, Immunology and Intensive Care Medicine, Department for Child and Adolescent Medicine, University Hospital Frankfurt, Frankfurt, Germany
| | - Andre M. Willasch
- Division for Stem Cell Transplantation, Immunology and Intensive Care Medicine, Department for Child and Adolescent Medicine, University Hospital Frankfurt, Frankfurt, Germany
| | - Gerd Horneff
- Center for Pediatric Rheumatology, Department of Pediatrics, Asklepios Clinic Sankt Augustin, Sankt Augustin, Germany
- Medical Faculty, University of Cologne, Cologne, Germany
| | - Genevieve Llanora
- Division of Allergy and Immunology, Department of Paediatrics, Khoo Teck Puat - National University Children’s Medical Institute, National University Health System, Singapore
| | - Lynette P. Shek
- Division of Allergy and Immunology, Department of Paediatrics, Khoo Teck Puat - National University Children’s Medical Institute, National University Health System, Singapore
- Department of Pediatrics, National University of Singapore, Singapore
| | - Louis Y.A. Chai
- Division of Infectious Diseases, Department of Medicine, National University Health System, Singapore
- Synthetic Biology for Clinical and Technological Innovation, Life Sciences Institute; Synthetic Biology Translational Research Program, National University of Singapore
- Department of Medicine, Yong Loo Lin School of Medicine, National University of Singapore, Singapore
| | - Sen Hee Tay
- Department of Medicine, Yong Loo Lin School of Medicine, National University of Singapore, Singapore
- Division of Rheumatology, Department of Medicine, National University Hospital, Singapore
| | - Hamid H. Rahimi
- Department of Pediatrics, Isfahan University of Medical Sciences, Isfahan, Iran
| | - Seyed Alireza Mahdaviani
- Pediatric Respiratory Diseases Research Center, National Research Institute of Tuberculosis and Lung Diseases, Shahid Beheshti University of Medical Sciences, Tehran, Iran
| | - Serdar Nepesov
- Department of Pediatric Allergy and Immunology, Istanbul Medipol University, Istanbul, Turkey
| | - Aziz A. Bousfiha
- Clinical Immunology Unit, Department of Pediatrics, King Hassan II University, Ibn-Rochd Hospital, Casablanca, Morocco
| | - Emine Hafize Erdeniz
- Division of Pediatric Infectious Diseases, Ondokuz Mayıs University, Samsun, Turkey
| | - Adem Karbuz
- Division of Pediatric Infectious Diseases, Okmeydani Training and Research Hospital, University of Health Sciences, Istanbul, Turkey
| | | | - Carmen Navarrete
- Department of Immunology, Hospital de Niños Roberto del Río, Santiago de Chile, Chile
| | - Mehdi Adeli
- Division of Allergy and Immunology, Sidra Medicine/Hamad Medical Corp., Doha, Qatar
| | - Lennart Hammarstrom
- Department of Biosciences and Nutrition, Karolinska Institute, Stockholm, Sweden
- Beijing Genomics Institute, Shenzhen, China
- Research Center for Immunodeficiencies, Pediatrics Center of Excellence, Children’s Medical Center, Tehran University of Medical Sciences, Tehran, Iran
| | - Hassan Abolhassani
- Department of Biosciences and Nutrition, Karolinska Institute, Stockholm, Sweden
- Research Center for Immunodeficiencies, Pediatrics Center of Excellence, Children’s Medical Center, Tehran University of Medical Sciences, Tehran, Iran
| | - Nima Parvaneh
- Research Center for Immunodeficiencies, Pediatrics Center of Excellence, Children’s Medical Center, Tehran University of Medical Sciences, Tehran, Iran
| | - Saleh Al Muhsen
- Immunology Research Laboratory, Department of Pediatrics, College of Medicine, King Saud University, Riyadh, Saudi Arabia
| | - Mohammed F. Alosaimi
- Immunology Research Laboratory, Department of Pediatrics, College of Medicine, King Saud University, Riyadh, Saudi Arabia
| | - Fahad Alsohime
- Pediatric Department, College of Medicine, King Saud University, Riyadh, Saudi Arabia
- Pediatric Intensive Care Unit, King Saud University Medical City, Riyadh, Saudi Arabia
| | - Maryam Nourizadeh
- Immunology, Asthma and Allergy Research Institute, Tehran University of Medical Sciences, Tehran, Iran
- Children's Medical Center, Pediatrics Center of Excellence, Tehran University of Medical Sciences, Tehran, Iran
| | - Mostafa Moin
- Immunology, Asthma and Allergy Research Institute, Tehran University of Medical Sciences, Tehran, Iran
- Children's Medical Center, Pediatrics Center of Excellence, Tehran University of Medical Sciences, Tehran, Iran
| | - Rand Arnaout
- Section of Allergy & Immunology, Department of Medicine, King Faisal Specialist Hospital and Research Center, Riyadh, Saudi Arabia
- Al Faisal University, Riyadh, Saudi Arabia
| | - Saad Alshareef
- Section of Allergy & Immunology, Department of Medicine, King Faisal Specialist Hospital and Research Center, Riyadh, Saudi Arabia
| | | | - Ferah Genel
- University of Health Sciences, Dr Behçet Uz Children’s Hospital, Division of Pediatric Immunology, Izmir, Turkey
| | - Roya Sherkat
- Acquired Immunodeficiency Research Center, Isfahan University of Medical Sciences, Isfahan, Iran
| | - Ayça Kiykim
- Pediatric Allergy and Immunology, Cerrahpasa Medical Faculty, Istanbul University-Cerrahpasa, Istanbul, Turkey
| | - Esra Yücel
- Division of Pediatric Allergy and Immunology, Istanbul Faculty of Medicine, Istanbul University, Istanbul, Turkey
| | - Sevgi Keles
- Division of Pediatric Allergy and Immunology, Meram Medical Faculty, Necmettin Erbakan University, Konya, Turkey
| | - Jacinta Bustamante
- St Giles Laboratory of Human Genetics of Infectious Diseases, Rockefeller Branch, The Rockefeller University, New York, NY
- Laboratory of Human Genetics of Infectious Diseases, Necker Branch, INSERM U1163, Paris, France
- Center for the Study of Primary Immunodeficiencies, Assistance Publique-Hôpitaux de Paris, Necker Hospital for Sick Children, Paris, France
| | - Laurent Abel
- St Giles Laboratory of Human Genetics of Infectious Diseases, Rockefeller Branch, The Rockefeller University, New York, NY
- Laboratory of Human Genetics of Infectious Diseases, Necker Branch, INSERM U1163, Paris, France
- Paris Cité University, Imagine Institute, Paris, France
| | - Jean-Laurent Casanova
- St Giles Laboratory of Human Genetics of Infectious Diseases, Rockefeller Branch, The Rockefeller University, New York, NY
- Laboratory of Human Genetics of Infectious Diseases, Necker Branch, INSERM U1163, Paris, France
- Paris Cité University, Imagine Institute, Paris, France
- Howard Hughes Medical Institute, New York, NY
- Deparment of Pediatrics, Necker Hospital for Sick Children, Paris, France
| | - Stéphanie Boisson-Dupuis
- St Giles Laboratory of Human Genetics of Infectious Diseases, Rockefeller Branch, The Rockefeller University, New York, NY
- Laboratory of Human Genetics of Infectious Diseases, Necker Branch, INSERM U1163, Paris, France
- Paris Cité University, Imagine Institute, Paris, France
| |
Collapse
|
7
|
Ozden A, Doneray H, Hafize Erdeniz E, Altinkaynak K, Igan H, Igan H. Clinical and Laboratory Findings by Serum Vitamin D Levels in Children with COVID-19. Eurasian J Med 2022; 54:285-291. [PMID: 36301009 PMCID: PMC9797750 DOI: 10.5152/eurasianjmed.2022.22213] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 01/05/2023] Open
Abstract
OBJECTIVE The studies on children with COVID-19 are very limited. The aim of this study is to reveal the effect of serum 25-hydroxy vitamin D level on clinical and laboratory parameters. MATERIALS AND METHODS The study included 74 children (35 boys and 39 girls) diagnosed with COVID-19. The retrospective data were obtained from the file records of the patients. Seventy-four patients were divided into 3 groups (group 1, deficient; group 2, insufficient; and group 3, sufficient) according to their serum 25-hydroxy vitamin D levels. RESULTS The mean age of all patients was 113.25 ± 64.55 months. The mean leucocyte count was substantially higher in group 3 compared to groups 1 and 2 (P = .05 and P = .002, respectively). The mean lymphocyte and platelet count in group 3 was remarkably higher than both groups 1 and 2 (P = .001 and P = .002; and P = .04 and P = .01, respectively). The mean serum parathyroid hormone concentration in group 1 was markedly higher than both groups 2 and 3 (P=.003 and P = .002, respectively) while the mean serum 25-hydroxy vitamin D level in group 1 was remarkably lower than both groups 2 and 3 (P=.001 and P=.001, respectively). Serum 25-hydroxy vitamin D concentrations were positively correlated with leucocyte, lymphocyte, and platelet counts (r=0.221, P=.05; r=0.396, P=.001; and r=0.249, P=.03, respectively) while there was a negative correlation with parathyroid hormone concentrations (r=-0,436, P=.001). CONCLUSION This study suggests that COVID-19 has a benign course in children and that serum 25-hydroxy vitamin D concentration may have a role in the lymphocyte count.
Collapse
Affiliation(s)
- Ayse Ozden
- Department of Pediatric Endocrinology, Erzurum Regional Training & Research Hospital, Erzurum, Turkey,Corresponding author: Ayse Ozden E-mail:
| | - Hakan Doneray
- Department of Pediatric Endocrinology, Atatürk University Faculty of Medicine, Erzurum, Turkey,Clinical Research Development and Design Application and Research Center, Atatürk University, Erzurum, Turkey
| | - Emine Hafize Erdeniz
- Department of Pediatric Infectious Diseases, Erzurum Regional Training & Research Hospital, Erzurum, Turkey
| | - Konca Altinkaynak
- Department of Biochemistry, Erzurum Regional Training & Research Hospital, Erzurum, Turkey
| | - Hakan Igan
- Department of Medical Microbiology, Erzurum Regional Training & Research Hospital, Erzurum, Turkey
| | | | | | | | | | | | | |
Collapse
|
8
|
Akyüz Özkan E, Erdeniz EH. Türkiye‘de Üçüncü Basamak Bir Hastaneye Başvuran Multisistem Enflamatuvar Sendromlu Çocuklardaki Organ Tutulumları. J Pediatr Inf 2022. [DOI: 10.5578/ced.20229815] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/15/2022]
|
9
|
Oygar PD, Büyükçam A, Sahbudak Bal Z, Dalgıç N, Bozdemir ŞE, Karbuz A, Çetin BŞ, Kara Y, Çetin C, Hatipoğlu N, Uygun H, Aygün FD, Hançerli Törün S, Şener Okur D, Yılmaz Çiftdoğan D, Tural Kara T, Yahşi A, Özer A, Öcal Demir S, Akkoç G, Turan C, Salı E, Şen S, Erdeniz EH, Kara SS, Emiroğlu M, Erat T, Aktürk H, Laçinel Gürlevik S, Sütçü M, Gayretli Aydın ZG, Yıldız Atikan B, Yeşil E, Güner Özenen G, Çelebi E, Efe K, Kizmaz Isancli D, Selver Durmuş H, Tekeli S, Karaaslan A, Bülbül L, Almış H, Kaba Ö, Ekemen Keleş Y, Yazıcıoğlu B, Bahtiyar Oğuz S, Ovalı HF, Doğan HH, Çelebi S, Çakir D, Karasulu B, Alkan G, Yenidoğan İ, Gül D, Parıltan Kücükalioğlu B, Avcu G, Kukul MG, Bilen M, Yaşar B, Üstün T, Kılıç Ö, Akın Y, Oral Cebeci S, Bucak İH, Sarı Yanartaş M, Şahin A, Arslanoglu S, Elevli M, Çoban R, Tuter Öz SK, Hatipoğlu H, Erkum İT, Turgut M, Demirbuğa A, Özçelik T, Çiftçi D, Sarı EE, Akkuş G, Hatipoğlu SS, Dinleyici EC, Hacimustafaoğlu M, Özkınay F, Kurugöl Z, Cengiz AB, Somer A, Tezer H, Kara A. Evaluation of vaccination status of health care workers for recommended vaccines and their acceptance of SARS-CoV-2 vaccines. Hum Vaccin Immunother 2022; 18:2044707. [PMID: 35714279 PMCID: PMC9248937 DOI: 10.1080/21645515.2022.2044707] [Citation(s) in RCA: 2] [Impact Index Per Article: 1.0] [Reference Citation Analysis] [What about the content of this article? (0)] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 12/05/2022] Open
Abstract
Introduction Health care workers (HCWs) are disproportionately exposed to infectious diseases and play a role in nosocomial transmission, making them a key demographic for vaccination. HCW vaccination rates are not optimal in many countries; hence, compulsory vaccination policies have been implemented in some countries. Although these policies are effective and necessary under certain conditions, resolving HCWs’ hesitancies and misconceptions about vaccines is crucial. HCWs have the advantage of direct contact with patients; hence, they can respond to safety concerns, explain the benefits of vaccination, and counter antivaccine campaigns that escalate during pandemics, as has been observed with COVID-19. Method A short survey was carried out in May–June 2020 on the vaccination status of HCWs working with pediatric patients with COVID-19. The survey inquired about their vaccination status (mumps/measles/rubella [MMR], varicella, influenza, and diphtheria/tetanus [dT]) and willingness to receive hypothetical future COVID-19 vaccines. The respondents were grouped according to gender, age, occupation, and region. Results In total, 4927 HCWs responded to the survey. Most were young, healthy adults. The overall vaccination rates were 57.8% for dT in the past 10 years, 44.5% for MMR, 33.2% for varicella, and 13.5% for influenza. Vaccination rates were the highest among physicians. The majority of HCWs (81%) stated that they would be willing to receive COVID-19 vaccines. Conclusion Although vaccination rates for well-established vaccines were low, a majority of HCWs were willing to receive COVID-19 vaccines when available. Education and administrative trust should be enhanced to increase vaccination rates among HCWs.
Collapse
|
10
|
Yilmaz Ciftdogan D, Ekemen Keles Y, Karbuz A, Cetin BS, Elmas Bozdemir S, Kepenekli Kadayifci E, Metin Akcan O, Ozer A, Erat T, Sutcu M, Buyukcam A, Belet N, Erdeniz EH, Dalgic Karabulut N, Hancerli Torun S, Oncel S, Orbak Z, Turel O, Gayretli Aydin ZG, Kilic O, Yahsi A, Kara Aksay A, Ergenc Z, Petmezci MT, Oflaz MB, Sarikaya R, Otar Yener G, Ozen S, Gul D, Arslan G, Kara SS, Demirkol D, Yazici Ozkaya P, Yozgat Y, Varan C, Kara M, Arga G, Yakut N, Kilic AO, Cakici O, Kucuk M, Kaba O, Karaoglu Asrak H, Bursal Duramaz B, Dalkiran T, Berna Anil A, Turgut M, Karapinar B, Somer A, Elmali F, Dinleyici EC, Ciftci E, Kara A. Multisystem inflammatory syndrome in children associated with COVID-19 in 101 cases from Turkey (Turk-MISC study). J Paediatr Child Health 2022; 58:1069-1078. [PMID: 35199895 PMCID: PMC9115147 DOI: 10.1111/jpc.15913] [Citation(s) in RCA: 12] [Impact Index Per Article: 6.0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Received: 04/13/2021] [Revised: 05/19/2021] [Accepted: 02/06/2022] [Indexed: 12/11/2022]
Abstract
AIM Multisystem inflammatory syndrome in children (MIS-C) may cause shock and even death in children. The aim of this study is to describe the clinical features, laboratory characteristics and outcome of children diagnosed with MIS-C in 25 different hospitals in Turkey. METHODS The retrospective study was conducted between 8 April and 28 October 2020 in 25 different hospitals from 17 cities. Data were collected from patients' medical records using a standardised form. Clinical and laboratory characteristics and outcomes according to different age groups, gender and body mass index percentiles were compared using multivariate logistic regression analysis. RESULTS The study comprised 101 patients, median age 7 years (interquartile range (IQR) 4.6-9.3); 51 (50.5%) were boys. Reverse-transcriptase polymerase chain reaction (PCR) assay was positive in 21/100 (21%) patients; 62/83 (74.6%) patients had positive serology for SARS-CoV-2. The predominant complaints were fever (100%), fatigue (n = 90, 89.1%), and gastrointestinal symptoms (n = 81, 80.2%). Serum C-reactive protein (in 101 patients, median 165 mg/L; range 112-228), erythrocyte sedimentation rate (73/84, median 53 mm/s; IQR 30-84) and procalcitonin levels (86/89, median 5 μg/L; IQR 0.58-20.2) were elevated. Thirty-eight patients (37.6%) required admission to intensive care. Kawasaki disease (KD) was diagnosed in 70 (69.3%) patients, 40 of whom had classical KD. Most patients were treated with intravenous immunoglobulin (n = 92, 91%) and glucocorticoids (n = 59, 58.4%). Seven patients (6.9%) died. CONCLUSION The clinical spectrum of MIS-C is broad, but clinicians should consider MIS-C in the differential diagnosis when persistent fever, fatigue and gastrointestinal symptoms are prominent. Most patients diagnosed with MIS-C were previously healthy. Immunomodulatory treatment and supportive intensive care are important in the management of cases with MIS-C. Glucocorticoids and intravenous immunoglobulins are the most common immunomodulatory treatment options for MIS-C. Prompt diagnosis and prompt treatment are essential for optimal management.
Collapse
Affiliation(s)
- Dilek Yilmaz Ciftdogan
- Department of Pediatric Infectious Diseases, Faculty of MedicineIzmir Katip Celebi UniversityIzmirTurkey,Department of Pediatric Infectious Diseases, Faculty of Medicine, Izmir Tepecik Training and Research HospitalUniversity of Health SciencesIzmirTurkey
| | - Yildiz Ekemen Keles
- Department of Pediatric Infectious Diseases, Faculty of Medicine, Izmir Tepecik Training and Research HospitalUniversity of Health SciencesIzmirTurkey
| | - Adem Karbuz
- Department of Pediatric Infectious DiseasesIstanbul Professor Doctor Cemil Tascioglu City HospitalIstanbulTurkey
| | - Benhur Sirvan Cetin
- Department of Pediatric Infectious Diseases, Faculty of MedicineErciyes UniversityKayseriTurkey
| | - Sefika Elmas Bozdemir
- Department of Pediatric Infectious DiseasesBursa Dortcelik Children's HospitalBursaTurkey
| | - Eda Kepenekli Kadayifci
- Department of Pediatric Infectious Diseases, Faculty of MedicinePendik Training and Research Hospital, Marmara UniversityIstanbulTurkey
| | - Ozge Metin Akcan
- Department of Pediatric Infectious Diseases, Faculty of MedicineNecmettin Erbakan University, Meram HospitalKonyaTurkey
| | - Arife Ozer
- Division of Pediatric Infectious Diseases, Van Training and Research HospitalUniversity of Health SciencesVanTurkey
| | - Tugba Erat
- Division of Pediatric Infectious DiseasesSanliurfa Training and Research HospitalSanliurfaTurkey
| | - Murat Sutcu
- Department of Pediatric Infectious Diseases, Faculty of MedicineIstinye University HospitalIstanbulTurkey
| | - Ayse Buyukcam
- Division of Pediatric Infectious DiseasesGaziantep CG Obstetrics and Children's HospitalGaziantepTurkey
| | - Nursen Belet
- Department of Pediatric Infectious Diseases, Faculty of MedicineDokuz Eylul University HospitalİzmirTurkey
| | - Emine Hafize Erdeniz
- Department of Pediatric Infectious DiseasesOndokuz Mayis University HospitalSamsunTurkey
| | - Nazan Dalgic Karabulut
- Division of Pediatric Infectious DiseasesHealth Sciences University Sisli Hamidiye Etfal Training and Research HospitalIstanbulTurkey
| | - Selda Hancerli Torun
- Department of Pediatric Infectious Diseases, Faculty of MedicineIstanbul University HospitalIstanbulTurkey
| | - Selim Oncel
- Department of Pediatric Infectious Diseases, Faculty of MedicineKocaeli University HospitalKocaeliTurkey
| | - Zerrin Orbak
- Department of Pediatrics, Faculty of Dentistry and MedicineAtatürk UniversityErzurumTurkey
| | - Ozden Turel
- Department of Pediatric Infectious Diseases, Faculty of MedicineBezmialem Vakif University HospitalIstanbulTurkey
| | - Zeynep Gokce Gayretli Aydin
- Department of Pediatric Infectious Diseases, Faculty of MedicineKaradeniz Teknik University HospitalTrabzonTurkey
| | - Omer Kilic
- Department of Pediatric Infectious Diseases, Faculty of MedicineOsmangazi University HospitalEskisehirTurkey
| | - Aysun Yahsi
- Division of Pediatric Infectious Diseases, Samsun Training and Research HospitalUniversity of Health SciencesSamsunTurkey
| | - Ahu Kara Aksay
- Department of Pediatric Infectious Diseases, Faculty of Medicine, Izmir Tepecik Training and Research HospitalUniversity of Health SciencesIzmirTurkey
| | - Zeynep Ergenc
- Department of Pediatric Infectious Diseases, Faculty of MedicinePendik Training and Research Hospital, Marmara UniversityIstanbulTurkey
| | - Mey Talip Petmezci
- Department of Intensive CareIstanbul Professor Doctor Cemil Tascioglu City HospitalIstanbulTurkey
| | - Mehmet Burhan Oflaz
- Department of Pediatric Cardiology, Faculty of MedicineNecmettin Erbakan University, Meram HospitalKonyaTurkey
| | - Remzi Sarikaya
- Division of Cardiology, Van Training and Research HospitalUniversity of Health SciencesVanTurkey
| | - Gülcin Otar Yener
- Division of Pediatric RomatologySanliurfa Training and Research HospitalSanliurfaTurkey
| | - Seval Ozen
- Department of Pediatric Infectious Diseases, Faculty of MedicineAdiyaman UniversityAdiyamanTurkey
| | - Doruk Gul
- Department of Pediatrics, Faculty of MedicineIstinye University HospitalIstanbulTurkey
| | - Gazi Arslan
- Department of Pediatric Intensive Care, Faculty of MedicineDokuz Eylul University HospitalİzmirTurkey
| | - Soner Sertan Kara
- Department of Pediatric Infectious Diseases, Faculty of MedicineAydin Adnan Menderes UniversityAydinTurkey
| | - Demet Demirkol
- Department of Pediatric Intensive Care, Faculty of MedicineIstanbul University HospitalIstanbulTurkey
| | - Pinar Yazici Ozkaya
- Department of Pediatric Intensive Care, Faculty of MedicineEge University HospitalIzmirTurkey
| | - Yilmaz Yozgat
- Department of Pediatric Cardiology, Faculty of MedicineBezmialem Vakif University HospitalIstanbulTurkey
| | - Celal Varan
- Department of Pediatric Cardiology, Faculty of MedicineAdiyaman UniversityAdiyamanTurkey
| | - Manolya Kara
- Division of Pediatric Infectious DiseasesNecip Fazil City HospitalKahramanmarasTurkey
| | - Gul Arga
- Department of Pediatric Infectious Diseases, Faculty of MedicineAnkara University HospitalAnkaraTurkey
| | - Nurhayat Yakut
- Department of Pediatric Infectious Diseases, Faculty of MedicinePendik Training and Research Hospital, Marmara UniversityIstanbulTurkey
| | - Ahmet Osman Kilic
- Department of Pediatrics, Faculty of MedicineNecmettin Erbakan University, Meram HospitalKonyaTurkey
| | - Ozlem Cakici
- Department of Pediatric Infectious Diseases, Faculty of MedicineKocaeli University HospitalKocaeliTurkey
| | - Mehmet Kucuk
- Division of Pediatric Cardiolgy, Samsun Training and Research HospitalUniversity of Health SciencesSamsunTurkey
| | - Ozge Kaba
- Department of Pediatric Infectious Diseases, Faculty of MedicineIstanbul University HospitalIstanbulTurkey
| | - Hatice Karaoglu Asrak
- Department of Pediatric Infectious Diseases, Faculty of MedicineDokuz Eylul University HospitalİzmirTurkey
| | - Burcu Bursal Duramaz
- Department of Pediatric Infectious Diseases, Faculty of MedicineBezmialem Vakif University HospitalIstanbulTurkey
| | - Tahir Dalkiran
- Division of Pediatric Intensive CareNecip Fazil City HospitalKahramanmarasTurkey
| | - Ayse Berna Anil
- Department of Pediatric Intensive Care, Faculty of MedicineIzmir Katip Celebi UniversityIzmirTurkey
| | - Mehmet Turgut
- Department of Pediatric Infectious Diseases, Faculty of MedicineAdiyaman UniversityAdiyamanTurkey
| | - Bulent Karapinar
- Department of Pediatric Intensive Care, Faculty of MedicineEge University HospitalIzmirTurkey
| | - Ayper Somer
- Department of Pediatric Infectious Diseases, Faculty of MedicineIstanbul University HospitalIstanbulTurkey
| | - Ferhan Elmali
- Department of BiostatisticsIzmir Katip Celebi UniversityIzmirTurkey
| | - Ener Cagri Dinleyici
- Department of Pediatrics, Faculty of MedicineEskisehir Osmangazi UniversityEskisehirTurkey
| | - Ergin Ciftci
- Department of Pediatric Infectious Diseases, Faculty of MedicineAnkara University HospitalAnkaraTurkey
| | - Ates Kara
- Department of Pediatric Infectious Diseases, Faculty of MedicineHacettepe University HospitalAnkaraTurkey
| |
Collapse
|
11
|
Yilmaz Ciftdogan D, Ekemen Keles Y, Cetin BS, Dalgic Karabulut N, Emiroglu M, Bagci Z, Buyukcam A, Erdeniz EH, Arga G, Yesil E, Cakici O, Karbuz A, Sahbudak Bal Z, Kara SS, Ozer A, Metin Akcan O, Elmas Bozdemir S, Anil AB, Uygun H, Kilic O, Hancerli Torun S, Umit Z, Sutcu M, Ozgokce Ozmen B, Karaoglu Asrak H, Alkan G, Kara Aksay A, Ugur C, Birbilen AZ, Bursal Duramaz B, Akyuz Ozkan E, Burakay O, Yildirim Arslan S, Karadag Oncel E, Celik SF, Kilic AO, Ozen S, Sarikaya R, Demirkol D, Arslan G, Turel O, Sert A, Sari E, Orbak Z, Sahin IO, Varan C, Akturk H, Tuter Oz SK, Durak F, Oflaz MB, Kara M, Karpuz D, Talip Petmezci M, Hatipoglu N, Oncel S, Turgut M, Elmali F, Somer A, Kuyucu N, Dinleyici EC, Kurugöl Z, Ciftci E, Kara A. COVID-19 associated multisystemic inflammatory syndrome in 614 children with and without overlap with Kawasaki disease-Turk MIS-C study group. Eur J Pediatr 2022; 181:2031-2043. [PMID: 35129668 PMCID: PMC8819197 DOI: 10.1007/s00431-022-04390-2] [Citation(s) in RCA: 14] [Impact Index Per Article: 7.0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Download PDF] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Received: 09/15/2021] [Revised: 01/09/2022] [Accepted: 01/21/2022] [Indexed: 12/17/2022]
Abstract
Multisystemic inflammatory syndrome (MIS-C) diagnosis remains difficult because the clinical features overlap with Kawasaki disease (KD). The study aims to highlight the clinical and laboratory features and outcomes of patients with MISC whose clinical manifestations overlap with or without KD. This study is a retrospective analysis of a case series designed for patients aged 1 month to 18 years in 28 hospitals between November 1, 2020, and June 9, 2021. Patient demographics, complaints, laboratory results, echocardiographic results, system involvement, and outcomes were recorded. A total of 614 patients were enrolled; the median age was 7.4 years (interquartile range (IQR) 3.9-12 years). A total of 277 (45.1%) patients with MIS-C had manifestations that overlapped with KD, including 92 (33.3%) patients with complete KD and 185 (66.7%) with incomplete KD. Lymphocyte and platelet counts were significantly lower in patients with MISC, overlapped with KD (lymphocyte count 1080 vs. 1280 cells × μL, p = 0.028; platelet count 166 vs. 216 cells × 103/μL, p < 0.001). The median serum procalcitonin levels were statistically higher in patients overlapped with KD (3.18 vs. 1.68 µg/L, p = 0.001). Coronary artery dilatation was statistically significant in patients with overlap with KD (13.4% vs. 6.8%, p = 0.007), while myocarditis was significantly more common in patients without overlap with KD features (2.6% vs 7.4%, p = 0.009). The association between clinical and laboratory findings and overlap with KD was investigated. Age > 12 years reduced the risk of overlap with KD by 66% (p < 0.001, 95% CI 0.217-0.550), lethargy increased the risk of overlap with KD by 2.6-fold (p = 0.011, 95% CI 1.244-5.439), and each unit more albumin (g/dl) reduced the risk of overlap with KD by 60% (p < 0.001, 95% CI 0.298-0.559). CONCLUSION Almost half of the patients with MISC had clinical features that overlapped with KD; in particular, incomplete KD was present. The median age was lower in patients with KD-like features. Lymphocyte and platelet counts were lower, and ferritin and procalcitonin levels were significantly higher in patients with overlap with KD. WHAT IS KNOWN • In some cases of MIS-C, the clinical symptoms overlap with Kawasaki disease. • Compared to Kawasaki disease, lymphopenia was an independent predictor of MIS-C. WHAT IS NEW • Half of the patients had clinical features that overlapped with Kawasaki disease. • In patients whose clinical features overlapped with KD, procalcitonin levels were almost 15 times higher than normal. • Lethargy increased the risk of overlap with KD by 2.6-fold in MIS-C patients. • Transient bradycardia was noted in approximately 10% of our patients after initiation of treatment.
Collapse
Affiliation(s)
- Dilek Yilmaz Ciftdogan
- Izmir Katip Celebi University, Izmir, Turkey
- Health Sciences University Tepecik Training and Research Hospital, Izmir, Turkey
| | - Yildiz Ekemen Keles
- Health Sciences University Tepecik Training and Research Hospital, Izmir, Turkey
| | | | - Nazan Dalgic Karabulut
- Health Sciences University Sisli Hamidiye Etfal Training and Research Hospital, Istanbul, Turkey
| | | | - Zafer Bagci
- University of Health Sciences Konya Health Application and Research Center, Konya, Turkey
| | - Ayse Buyukcam
- Gaziantep CG Obstetrics and Children’s Hospital, Gaziantep, Turkey
| | | | - Gul Arga
- Ankara University Hospital, Ankara, Turkey
| | | | | | - Adem Karbuz
- Istanbul Professor Doctor Cemil Tascioglu City Hospital, Istanbul, Turkey
| | | | | | - Arife Ozer
- Van Training and Research Hospital, Van, Turkey
| | | | | | | | | | - Omer Kilic
- Osmangazi University Hospital, Eskisehir, Turkey
| | | | | | - Murat Sutcu
- Istinye University Hospital, Istanbul, Turkey
| | | | | | | | - Ahu Kara Aksay
- Health Sciences University Tepecik Training and Research Hospital, Izmir, Turkey
| | - Cuneyt Ugur
- University of Health Sciences Konya Health Application and Research Center, Konya, Turkey
| | | | | | | | | | | | - Eda Karadag Oncel
- Health Sciences University Tepecik Training and Research Hospital, Izmir, Turkey
| | | | | | - Seval Ozen
- Adiyaman University Hospital, Adiyaman, Turkey
| | | | | | - Gazi Arslan
- Dokuz Eylul University Hospital, İzmir, Turkey
| | - Ozden Turel
- Bezmialem Vakif University Hospital, Istanbul, Turkey
| | - Ahmet Sert
- Selcuk University Hospital, Konya, Turkey
| | - Ergul Sari
- Bakirkoy Sadi Konuk Children Hospital, Istanbul, Turkey
| | | | | | - Celal Varan
- Adiyaman University Hospital, Adiyaman, Turkey
| | | | | | - Fatih Durak
- Gaziantep CG Obstetrics and Children’s Hospital, Gaziantep, Turkey
| | | | | | | | - Mey Talip Petmezci
- Istanbul Professor Doctor Cemil Tascioglu City Hospital, Istanbul, Turkey
| | | | - Selim Oncel
- Kocaeli University Hospital, Kocaeli, Turkey
| | | | | | - Ayper Somer
- Istanbul University Hospital, Istanbul, Turkey
| | | | | | | | | | - Ates Kara
- Hacettepe University Hospital, Ankara, Turkey
| |
Collapse
|
12
|
Akaslan Kara A, Çay Ü, Yalçınkaya R, Erdeniz EH, Tural Kara T, Özdemir H, Güner Özenen G, Polat M, Gayretli Aydın ZG, Alkan G, Kepenekli E, Gündeşlioğlu ÖÖ, Kıymet E, Birinci A, Kibar F, Böncüoğlu E, Şahbudak Bal Z, Alabaz D, Çiftçi E, Tanır G, Bayram N, Cengiz AB, Devrim İ. Bloodstream infections due to Trichosporon species in paediatric patients: Results from the first national study from Turkey. J Mycol Med 2021; 32:101229. [PMID: 34911023 DOI: 10.1016/j.mycmed.2021.101229] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 09/13/2021] [Revised: 11/17/2021] [Accepted: 11/19/2021] [Indexed: 11/16/2022]
Abstract
BACKGROUND Invasive Trichosporon infections are rarely seen opportunistic fungal infections in children and mainly affect immunocompromised patients. This multicenter retrospective study has rewieved the characteristics, risk factors, treatment modalities and outcomes of bloodstream infections caused by Trichosporon species in children diagnosed over the past ten years in Turkey. METHODS The study was performed with the participation of 12 of 55 hospitals invited from Turkey. In each center, the patients with bloodstream infections caused by Trichosporon spp. between January 2010 and December 2020 were retrospectively ascertained and the results were reported to the study coordinator by means of a simple case report. Data were collected on patient demographics, underlying condition(s), treatment of.infections caused by Trichosporon spp, and 7 and 30- day mortality rates. RESULTS A total of 28 cases with fungemia caused by Trichosporon spp. were included in the study. The most common underlying disease was paediatric cancers (39.3%). T. asahii infections were detected in 78.5 % (n=22) of patients. A various spectrum of antifungal treatment regimens were used including intravenous amphotericin B monotherapy in 35.7%, intravenous amphotericin B and voriconazole combination in 32.1% and intravenous voriconazole monotherapy in 28.6% of the patients. The overall mortality rate was 28.5 %. The mortality rates were 12.5% in the voricanozole, 30% in the amphotericin B and 33.3% in combined voriconazole -amphotericin B arms CONCLUSIONS: Invasive Trichosporon infections with an important impact of patients quality of life are almost related to underlying diseases with an overall mortality rate of 28.5%. Voriconazole was found to be associated with lower mortality rates when compared with other treatment regimens.
Collapse
Affiliation(s)
- Aybüke Akaslan Kara
- Department of Pediatric Infectious Diseases, Dr. Behçet Uz Children's Diseases and Surgery Training and Research Hospital, İzmir, Turkey.
| | - Ümmühan Çay
- Department of Pediatric Infectious Diseases, Cukurova University Faculty of Medicine, Adana, Turkey
| | - Rumeysa Yalçınkaya
- Department of Pediatric Infectious Diseases, Dr. Sami Ulus Children's Health and Diseases Training and Research Hospital, Ankara, Turkey
| | - Emine Hafize Erdeniz
- Department of Pediatric Infectious Diseases, Ondokuz Mayis University Faculty of Medicine, Samsun, Turkey
| | - Tuğçe Tural Kara
- Department of Pediatric Infectious Diseases, Akdeniz University Faculty of Medicine, Antalya, Turkey
| | - Halil Özdemir
- Department of Pediatric Infectious Diseases, Ankara University Faculty of Medicine, Ankara, Turkey
| | - Gizem Güner Özenen
- Department of Pediatric Infectious Diseases, Ege University Faculty of Medicine, İzmir, Turkey
| | - Meltem Polat
- Department of Pediatric Infectious Diseases, Pamukkale University Faculty of Medicine, Denizli, Turkey
| | - Zeynep Gökçe Gayretli Aydın
- Department of Pediatric Infectious Diseases, Karadeniz Technical University Faculty of Medicine, Trabzon, Turkey
| | - Gülsüm Alkan
- Department of Pediatric Infectious Diseases, Selcuk University Faculty of Medicine, Konya, Turkey
| | - Eda Kepenekli
- Department of Pediatric Infectious Diseases, Marmara University Faculty of Medicine, Istanbul, Turkey
| | - Özlem Özgür Gündeşlioğlu
- Department of Pediatric Infectious Diseases, Cukurova University Faculty of Medicine, Adana, Turkey
| | - Elif Kıymet
- Department of Pediatric Infectious Diseases, Dr. Behçet Uz Children's Diseases and Surgery Training and Research Hospital, İzmir, Turkey
| | - Asuman Birinci
- Department of Microbiology, Ondokuz Mayis University Faculty of Medicine, Samsun, Turkey
| | - Filiz Kibar
- Department of Microbiology, Cukurova University Faculty of Medicine, Adana, Turkey
| | - Elif Böncüoğlu
- Department of Pediatric Infectious Diseases, Dr. Behçet Uz Children's Diseases and Surgery Training and Research Hospital, İzmir, Turkey
| | - Zümrüt Şahbudak Bal
- Department of Pediatric Infectious Diseases, Ege University Faculty of Medicine, İzmir, Turkey
| | - Derya Alabaz
- Department of Pediatric Infectious Diseases, Cukurova University Faculty of Medicine, Adana, Turkey
| | - Ergin Çiftçi
- Department of Pediatric Infectious Diseases, Ankara University Faculty of Medicine, Ankara, Turkey
| | - Gönül Tanır
- Department of Pediatric Infectious Diseases, Dr. Sami Ulus Children's Health and Diseases Training and Research Hospital, Ankara, Turkey
| | - Nuri Bayram
- Department of Pediatric Infectious Diseases, Dr. Behçet Uz Children's Diseases and Surgery Training and Research Hospital, İzmir, Turkey
| | - Ali Bülent Cengiz
- Department of Pediatric Infectious Diseases, Hacettepe University Faculty of Medicine, Ankara, Turkey
| | - İlker Devrim
- Department of Pediatric Infectious Diseases, Dr. Behçet Uz Children's Diseases and Surgery Training and Research Hospital, İzmir, Turkey
| |
Collapse
|
13
|
Oygar PD, Büyükçam A, Bal ZŞ, Dalgıç N, Bozdemir ŞE, Karbuz A, Çetin BŞ, Kara Y, Çetin C, Hatipoğlu N, Uygun H, Aygün FD, Törün SH, Okur DŞ, Çiftdoğan DY, Kara TT, Yahşi A, Özer A, Demir SÖ, Akkoç G, Turan C, Salı E, Şen S, Erdeniz EH, Kara SS, Emiroğlu M, Erat T, Aktürk H, Gürlevik SL, Sütçü M, Aydın ZGG, Atikan BY, Yeşil E, Güner G, Çelebi E, Efe K, İşançlı DK, Durmuş HS, Tekeli S, Karaaslan A, Bülbül L, Almış H, Kaba Ö, Keleş YE, Yazıcıoğlu B, Oğuz ŞB, Ovalı HF, Doğan HH, Çelebi S, Çakır D, Karasulu B, Alkan G, Yenidoğan İ, Gül D, Küçükalioğlu BP, Avcu G, Kukul MG, Bilen M, Yaşar B, Üstün T, Kılıç Ö, Akın Y, Cebeci SO, Bucak IH, Yanartaş MS, Şahin A, Arslanoğlu S, Elevli M, Çoban R, Öz ŞKT, Hatipoğlu H, Erkum İT, Turgut M, Demirbuğa A, Özçelik T, Çiftçi D, Sarı EE, Akkuş G, Hatipoğlu SS, Dinleyici EÇ, Hacımustafaoğlu M, Özkınay F, Kurugöl Z, Cengiz AB, Somer A, Tezer H, Kara A. SARS-CoV-2 seropositivity among pediatric health care personnel after the first peak of the pandemic: nationwide surveillance in Turkey. Int J Infect Dis 2021; 113:184-189. [PMID: 34592441 PMCID: PMC8474801 DOI: 10.1016/j.ijid.2021.09.054] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 06/09/2021] [Revised: 08/31/2021] [Accepted: 09/22/2021] [Indexed: 11/19/2022] Open
Abstract
Background Understanding SARS-CoV-2 seroprevalence among health care personnel is important to explore risk factors for transmission, develop elimination strategies and form a view on the necessity and frequency of surveillance in the future. Methods We enrolled 4927 health care personnel working in pediatric units at 32 hospitals from 7 different regions of Turkey in a study to determine SARS Co-V-2 seroprevalence after the first peak of the COVID-19 pandemic. A point of care serologic lateral flow rapid test kit for immunoglobulin (Ig)M/IgG was used. Seroprevalence and its association with demographic characteristics and possible risk factors were analyzed. Results SARS-CoV-2 seropositivity prevalence in health care personnel tested was 6.1%. Seropositivity was more common among those who did not universally wear protective masks (10.6% vs 6.1%). Having a COVID-19-positive co-worker increased the likelihood of infection. The least and the most experienced personnel were more likely to be infected. Most of the seropositive health care personnel (68.0%) did not suspect that they had previously had COVID-19. Conclusions Health surveillance for health care personnel involving routine point-of-care nucleic acid testing and monitoring personal protective equipment adherence are suggested as important strategies to protect health care personnel from COVID-19 and reduce nosocomial SARS-CoV-2 transmission.
Collapse
|
14
|
Oygar PD, Büyükçam A, Şahbudak Bal Z, Dalgıç N, Bozdemir ŞE, Karbuz A, Çetin BŞ, Kara Y, Çetin C, Hatipoğlu N, Uygun H, Aygün FD, Hançerli Törün S, Şener Okur D, Yılmaz Çiftdoğan D, Tural Kara T, Yahşi A, Özer A, Öcal Demir S, Akkoç G, Turan C, Salı E, Şen S, Erdeniz EH, Kara SS, Emiroğlu M, Erat T, Aktürk H, Laçinel Gürlevik S, Sütçü M, Gayretli Aydın ZG, Atikan BY, Yeşil E, Güner G, Çelebi E, Efe K, Kızmaz İşançlı D, Durmuş HS, Tekeli S, Karaarslan A, Bülbül L, Almış H, Kaba Ö, Ekemen Keleş Y, Yazıcıoğlu B, Bahtiyar Oğuz Ş, Ovalı HF, Doğan HH, Çelebi S, Çakır D, Karasulu B, Alkan G, Yenidoğan İ, Gül D, Parıltan Küçükalioğlu B, Avcu G, Kukul MG, Bilen M, Yaşar B, Üstün T, Kılıç Ö, Akın Y, Oral Cebeci S, Turgut M, Sarı Yanartaş M, Şahin A, Arslanoğlu S, Elevli M, Tüter Öz ŞK, Hatipoğlu H, Erkum İT, Demirbuğa A, Özçelik T, Ergül Sarı E, Akkuş G, Hatipoğlu SS, Dinleyici EÇ, Hacımustafaoğlu M, Özkınay F, Kurugöl Z, Cengiz AB, Somer A, Tezer H, Kara A. Education of Healthcare Personnel Working with Pediatric Patients During COVID-19 Pandemic within the Framework of Infection Control. J Pediatr Inf 2020. [DOI: 10.5578/ced.202061] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/15/2022]
Abstract
Objective: In the early stages of any epidemic caused by new emerging pathogens healthcare personnel is subject to a great risk. Pandemic caused by SARS-CoV-2, proved to be no exception. Many healthcare workers died in the early stages of pandemic due to inadequate precautions and insufficient protection. It is essential to protect and maintain the safety of healthcare personnel for the confinement of pandemic as well as continuity of qualified healthcare services which is already under strain. Educating healthcare personnel on appropiate use of personal protective equipment (PPE) is as essential as procuring them. Material and Methods: A survey is conducted on 4927 healthcare personnel working solely with pediatric patients from 32 different centers. Education given on PPE usage were questioned and analyzed depending on age, sex, occupation and region. Results: Among four thousand nine hundred twelve healthcare personnel from 32 different centers 91% (n= 4457) received education on PPE usage. Of those who received education only 36% was given both theoretical and applied education. Although there was no differences among different occupation groups, receiving education depended on regions. Conclusion: It is essential to educate healthcare personnel appropiately nationwidely for the continuity of qualified healthcare services during the pandemic.
Collapse
|
15
|
Oygar PD, Büyükçam A, Şahbudak Bal Z, Dalgıç N, Bozdemir ŞE, Karbuz A, Çetin BŞ, Kara Y, Çetin C, Hatipoğlu N, Uygun H, Aygün FD, Hançerli Törün S, Şener Okur D, Yılmaz Çiftdoğan D, Tural Kara T, Yahşi A, Özer A, Öcal Demir S, Akkoç G, Turan C, Salı E, Şen S, Erdeniz EH, Kara SS, Emiroğlu M, Erat T, Aktürk H, Laçinel Gürlevik S, Sütçü M, Gayretli Aydın ZG, Atikan BY, Yeşil E, Güner G, Çelebi E, Efe K, Kızmaz İşançlı D, Durmuş HS, Tekeli S, Karaarslan A, Bülbül L, Almış H, Kaba Ö, Ekemen Keleş Y, Yazıcıoğlu B, Bahtiyar Oğuz Ş, Ovalı HF, Doğan HH, Çelebi S, Çakır D, Karasulu B, Alkan G, Yenidoğan İ, Gül D, Parıltan Küçükalioğlu B, Avcu G, Kukul MG, Bilen M, Yaşar B, Üstün T, Kılıç Ö, Akın Y, Oral Cebeci S, Bucak İH, Turgut M, Sarı Yanartaş M, Şahin A, Arslanoğlu S, Elevli M, Tüter Öz ŞK, Hatipoğlu H, Erkum İT, Demirbuğa A, Özçelik T, Ergül Sarı E, Akkuş G, Hatipoğlu SS, Dinleyici EÇ, Hacımustafaoğlu M, Özkınay F, Kurugöl Z, Cengiz AB, Somer A, Tezer H, Kara A. COVID-19 Pandemisinde Enfeksiyon Kontrol Çalışmaları Çerçevesinde Çocuk Hastalarla Çalışan Sağlık Personeli Eğitimi. J Pediatr Inf 2020. [DOI: 10.5578/ced.70235] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/15/2022]
Abstract
Objective: In the early stages of any epidemic caused by new emerging pathogens healthcare personnel is subject to a great risk. Pandemic caused by SARS-CoV-2, proved to be no exception. Many healthcare workers died in the early stages of pandemic due to inadequate precautions and insufficient protection. It is essential to protect and maintain the safety of healthcare personnel for the confinement of pandemic as well as continuity of qualified healthcare services which is already under strain. Educating healthcare personnel on appropiate use of personal protective equipment (PPE) is as essential as procuring them. Material and Methods: A survey is conducted on 4927 healthcare personnel working solely with pediatric patients from 32 different centers. Education given on PPE usage were questioned and analyzed depending on age, sex, occupation and region. Results: Among four thousand nine hundred twelve healthcare personnel from 32 different centers 91% (n= 4457) received education on PPE usage. Of those who received education only 36% was given both theoretical and applied education. Although there was no differences among different occupation groups, receiving education depended on regions. Conclusion: It is essential to educate healthcare personnel appropiately nationwidely for the continuity of qualified healthcare services during the pandemic.
Collapse
|
16
|
Erdeniz EH, Dursun A. Evaluation of Inappropriate Antibiotic Use in Pediatric Patients: Point-prevalence Study. J Pediatr Inf 2020. [DOI: 10.5578/ced.69088] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/15/2022]
|
17
|
|
18
|
Gayretli Aydın ZG, Büyükcam A, Kara A, Karbuz A, Soysal A, Aktaş Kapısız A, Özkaya Parlakay A, Somer A, Budan Çalışkan AB, Aldemir Kocabaş B, Şener Okur D, Yılmaz Çiftdoğan D, Arısoy ES, Kocabaş E, Çiftçi E, Erduran E, Vardar F, Tanır G, Şensoy SG, Bayhan Gİ, Devrim İ, Çelik M, Özen M, Kosker M, Ergüven M, Dalgıç N, Hatipoğlu N, Öz FN, Belet N, Metin Akcan Ö, Ceylan Ö, Şiraneci R, Elmas Bozdemir Ş, Özkasap S, Çelebi S, Çelik Ü, Camcıoğlu Y, Akaslan Kara A, Küpeli B, Gülhan B, Albayrak E, Erdeniz EH, Yasa EO, Türkkan E, Tezer H, Sütçü M, Bayram N, Hatipoğlu S, Öncel S, Çelik T, Altuner Torun Y, Köksal Y, Çay Ü, Kara A, Yörük MA, Bedir Demirdağ T. Türkiye’ de Pediatrik Nötropenik Hasta İzlemi. J Pediatr Inf 2019. [DOI: 10.5578/ced.201954] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/15/2022]
|
19
|
Gayretli Aydın ZG, Büyükcam A, Kara A, Karbuz A, Soysal A, Aktaş Tapısız A, Özkaya Parlakay A, Somer A, Budan Çalışkan AB, Aldemir Kocabaş B, Şener Okur D, Yılmaz Çiftdoğan D, Arısoy ES, Kocabaş E, Çiftçi E, Erduran E, Vardar F, Tanır G, Şensoy SG, Bayhan Gİ, Devrim İ, Çelik M, Özen M, Kosker M, Ergüven M, Dalgıç N, Hatipoğlu N, Öz FN, Belet N, Metin Akcan Ö, Ceylan Ö, Şiraneci R, Elmas Bozdemir Ş, Özkasap S, Çelebi S, Çelik Ü, Camcıoğlu Y, Akaslan Kara A, Küpeli B, Gülhan B, Albayrak E, Erdeniz EH, Yasa EO, Türkkan E, Tezer H, Sütçü M, Bayram N, Hatipoğlu S, Öncel S, Çelik T, Altuner Torun Y, Köksal Y, Çay Ü, Kara A, Yörük MA, Bedir Demirdağ T. Pediatric Neutropenic Patients Care in Turkey. J Pediatr Inf 2019. [DOI: 10.5578/ced.68192] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/15/2022]
|
20
|
Büyükkaragöz B, Koçak M, Erdeniz EH, Yılmaz AÇ, Işın UU, Takcı Z, Güreşci S, Günbey S. Eight-year old male patient with painful swelling and eruptions in the legs. Turk Arch Pediatr 2014; 49:171-4. [PMID: 26078657 DOI: 10.5152/tpa.2014.1707] [Citation(s) in RCA: 2] [Impact Index Per Article: 0.2] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 11/11/2013] [Accepted: 01/10/2014] [Indexed: 11/22/2022]
Affiliation(s)
- Bahar Büyükkaragöz
- Unit of Pediatric Nephrology, Keçiören Training and Research Hospital, Ankara, Turkey
| | - Mesut Koçak
- Clinic of Pediatrics, Keçiören Training and Research Hospital, Ankara, Turkey
| | | | - Aysun Çaltık Yılmaz
- Unit of Pediatric Nephrology, Keçiören Training and Research Hospital, Ankara, Turkey
| | - Uğur Ufuk Işın
- Clinic of Pediatrics, Keçiören Training and Research Hospital, Ankara, Turkey
| | - Zennure Takcı
- Unit of Dermatology, Keçiören Training and Research Hospital, Ankara, Turkey
| | - Servet Güreşci
- Unit of Pathology, Keçiören Training and Research Hospital, Ankara, Turkey
| | - Sacit Günbey
- Clinic of Pediatrics, Keçiören Training and Research Hospital, Ankara, Turkey
| |
Collapse
|